Finanzen von Hinge Health Inc (HNGE)HNGEHinge Health Inc

Evaluating the bottom line, Hinge Health, Inc. maintains a gross margin of 86.44%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 19.00%, while the net margin is 20.53%. These profitability ratios, combined with a Return on Equity (ROE) of 41.41%, provide a clear picture of how effectively HNGE converts its operational activities into shareholder value.

In the context of the broader market, HNGE competes directly with industry leaders such as ZETA and OTEX. With a market capitalization of $8.47B, it holds a leading position in the sector. When comparing efficiency, HNGE's gross margin of 86.44% stands against ZETA's 54.00% and OTEX's 65.49%. Such benchmarking helps identify whether Hinge Health, Inc. is trading at a premium or discount relative to its financial performance.

Hinge Health has shown strong revenue growth, with Q2 2026 revenue at $212.82 million and a gross margin of 86.44%. However, the company has faced net income fluctuations, with a recent net income of $43.10 million in Q2 2026, indicating some instability.